You are here
Bivalent COVID-19 booster outperforms monovalent version --new study
Primary tabs
Bivalent COVID-19 booster outperforms monovalent version --new study
Thu, 2023-07-20 14:36 — mike kraftA new Italian study finds that estimated relative vaccine effectiveness (rVE) was 49.3% for the bivalent (two-strain) booster and 26.9% for the monovalent (single-strain) booster, with protection lasting at least 4 months for the bivalent booster and waning fast for the monovalent version. The study appears in The Lancet Infectious Diseases.
...
General Topic Tags:
Problem, Solution, SitRep, or ?:
Groups this Group Post belongs to:
- Private group -
Recent Comments